Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity

Hepatology

Volumn 51, Issue 4, 2010, Pages 1354-1362

  Wang, Hua ^a   Park, Ogyi ^a   Lafdil, Fouad ^a   Shen, Kezhen ^a   Horiguchi, Norio ^a   Yin, Shi ^a   Fu, Xin Yuan ^b   Kunos, George ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; INFLAMMATION; INNATE IMMUNITY; LIVER CELL; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL;

ANIMALS; HEPATECTOMY; HEPATOCYTES; IMMUNITY, INNATE; INTERFERON-GAMMA; LIVER REGENERATION; MALE; MICE; MYELOID CELLS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 77950625278     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23430     Document Type: Article

References (32)

1. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300.
2. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. HEPATOLOGY 2006; 43:S45-S53.
3. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
4. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration. J Am Coll Surg 2003;197:634-659.
5. Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 1985;249:R551-R562.
6. Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto N. Proinflammatory cytokine production in liver regeneration is Myd88-de-pendent, but independent of Cd14, Tlr2, and Tlr4. J Immunol 2006;176: 2522-2528.
7. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. HEPATOLOGY 2005;41:443-450.
8. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
9. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH. Interleukin 6 is important for survival after partial hepatectomy in mice. HEPATOLOGY 2003;38:674-682.
10. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, et al. Inter-leukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003;278:11281-11288. (Pubitemid 36792685)
11. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME,et al. Expression ofsuppressors of cytokine signaling during liver regeneration. J Clin Invest 2001;107:1285-1292.
12. Li W, Liang X, Kellendonk C, Poli V, Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411-28417.
13. Helling TS, Dhar A, Helling TS Jr, Moore BT, VanWay CW. Partial hepatectomy with or without endotoxin does not promote apoptosis in the rat liver. J Surg Res 2004;116:1-10.
14. Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000;6:920-923.
15. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, et al. Metformin prevents endotoxin-induced liver injury after partial hepatec-tomy. J Pharmacol Exp Ther 2006;316:1053-1061.
16. Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 2003; 112:978-980.
17. Takeda K, Clausen BE, Kaisho T, TsujimuraT, TeradaN, Forster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
18. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, et al. Cell type-dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008;134:1148-1158.
19. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008;3:1167-1170.
20. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leu-koc Biol 2008;83:64-70.
21. Sun R, Park O, Horiguchi N, Kulkarni S, Jeong WI, Sun HY, etal. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. HEPATOLOGY 2006;44:955-966.
22. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. HEPATOLOGY 1997;25:889-895.
23. Selzner N, Selzner M, Odermatt B, Tian Y, Van Rooijen N, Clavien PA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release ofTNF-alpha/IL-6 in mice. Gastroenterology 2003;124:692-700.
24. YamadaY, KirillovaI, PeschonJJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-1446.
25. Moh A, Iwamoto Y, Chai GX, Zhang SS, Kano A, Yang DD, et al. Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 2007;87:1018-1028.
26. Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J Leukoc Biol 2001;70:348-356.
27. Song MM, Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 1998;273:35056-35062.
28. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-depen-dent IL-6 production. Science 2007;317:121-124.
29. \ mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004; 36:969-977.
30. Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 2009;28:961-972.
31. Capussotti L, Vigano L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 2009;96:88-94.
32. Duong FH, FilipowiczM, TripodiM, La Monica N, HeimMH. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004;126:263-277.